The Role of Mitochondrial Transition Pore in the Realization of the Cardioprotective Effect of Probiotic Strains in Systemic Inflammatory Response in Rats.
Y Y Borshchev, S M Minasyan, I Y Burovenko, V Y Borshchev, A D Gordeev, O V Borshcheva, M M Galagudza
{"title":"The Role of Mitochondrial Transition Pore in the Realization of the Cardioprotective Effect of Probiotic Strains in Systemic Inflammatory Response in Rats.","authors":"Y Y Borshchev, S M Minasyan, I Y Burovenko, V Y Borshchev, A D Gordeev, O V Borshcheva, M M Galagudza","doi":"10.1007/s10517-026-06677-y","DOIUrl":null,"url":null,"abstract":"<p><p>The study tested the hypothesis of the involvement of the mitochondrial transition pore (MTP) in the cardioprotective effect of probiotics under conditions of a systemic inflammatory response (SIR) in rats. After the induction of SIR, Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis were administered orally to rats for 7 days. The MTP blocker cyclosporine A was injected intravenously at a dose of 10 mg/kg 20 min before the start of the isolated heart perfusion using the Langendorff technique. Global 30-min ischemia followed by 90-min reperfusion was modeled, after which the size of the necrosis zone was measured. In the SIR groups, the size of the necrosis zone was significantly greater than in the control (61 (57; 64)% vs (35 (35; 37)%; p < 0.05); an increase in the levels of proinflammatory cytokines and leukocytosis was also noted. In rats treated with probiotics, the size of the necrosis zone were smaller than in the SIR group (47 (34; 52)%; p < 0.05). Injection of MTP blocker cyclosporine A partially abolished the cardioprotective effect of probiotics (the size of the necrosis zone was 54 (50; 55)%; p < 0.05), which indicates the involvement of MTP opening in the mechanisms of probiotic cardioprotection.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"567-570"},"PeriodicalIF":0.7000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-026-06677-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The study tested the hypothesis of the involvement of the mitochondrial transition pore (MTP) in the cardioprotective effect of probiotics under conditions of a systemic inflammatory response (SIR) in rats. After the induction of SIR, Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis were administered orally to rats for 7 days. The MTP blocker cyclosporine A was injected intravenously at a dose of 10 mg/kg 20 min before the start of the isolated heart perfusion using the Langendorff technique. Global 30-min ischemia followed by 90-min reperfusion was modeled, after which the size of the necrosis zone was measured. In the SIR groups, the size of the necrosis zone was significantly greater than in the control (61 (57; 64)% vs (35 (35; 37)%; p < 0.05); an increase in the levels of proinflammatory cytokines and leukocytosis was also noted. In rats treated with probiotics, the size of the necrosis zone were smaller than in the SIR group (47 (34; 52)%; p < 0.05). Injection of MTP blocker cyclosporine A partially abolished the cardioprotective effect of probiotics (the size of the necrosis zone was 54 (50; 55)%; p < 0.05), which indicates the involvement of MTP opening in the mechanisms of probiotic cardioprotection.
期刊介绍:
Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005.
World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells.
The Russian Volume Year is published in English from April.